Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Minimally Invasive
100%
Minimally Invasive Surgery
100%
Transanal Total Mesorectal Excision (taTME)
100%
Rectal Cancer
100%
Neoadjuvant Therapy
25%
Disease-free Survival
25%
Disease-specific Survival
25%
Long-term Oncological Outcomes
25%
Subgroup Analysis
12%
3-group
12%
Body Mass Index
12%
Overall Survival
12%
Local Recurrence Rate
12%
Adjuvant Therapy
12%
Patient Characteristics
12%
Postoperative Complications
12%
Patient Outcomes
12%
Retrospective Case Series
12%
Serious Complications
12%
TNM Staging
12%
5-year Survival
12%
Surgery Groups
12%
Tumor Location
12%
Index Tumor
12%
Local Recurrence
12%
Oncological Outcomes
12%
Open Surgery
12%
Oncologic
12%
Open Groups
12%
Circumferential Resection Margin
12%
Tumor-node-metastasis
12%
P-53
12%
Postoperative Complication Rate
12%
Robotic Total Mesorectal Excision
12%
Laparoscopic Total Mesorectal Excision
12%
Pathologic N1
12%
Open Operation
12%
Medicine and Dentistry
Rectum Cancer
100%
Minimally Invasive Procedure
100%
Total Mesorectal Excision
100%
Neoplasm
25%
Postoperative Complication
25%
Overall Survival
25%
Disease Free Survival
25%
Disease Specific Survival
25%
Recurrent Disease
12%
Recurrence Risk
12%
Subgroup Analysis
12%
Body Mass Index
12%
Surgical Margin
12%
Adjuvant Therapy
12%
Neoadjuvant Therapy
12%
Patient Characteristics
12%
Open Surgery
12%
Case-Control Study
12%
Median Follow Up
12%
Open Operation
12%